Free Trial

Cizzle Biotechnology (CIZ) Chart & Stock Price History

Cizzle Biotechnology logo
GBX 3.11 -0.04 (-1.27%)
As of 11:22 AM Eastern

Cizzle Biotechnology Stock Price Performance

The Cizzle Biotechnology (CIZ) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 62.83%, with a year-to-date return of 117.48%. In the past month, the fund has increased 24.40%, reflecting recent market activity.

As of the latest close, Cizzle Biotechnology traded at GBX 3.30 with a market cap of £13.08 million and volume of 1.63 million shares. Five years ago, the fund traded at GBX 34.83, representing a 91.07% decrease over that period. At the time, it had a market cap of £43.18 million and a volume of 282 shares.

Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+8.17%
1 Month
Performance
+24.40%
3 Month
Performance
+119.01%
Year-To-Date
Performance
+117.48%
1 Year
Performance
+62.83%
5 Year
Performance
-91.07%

CIZ Stock Chart for Friday, June, 5, 2026

Cizzle Biotechnology Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/05/2026GBX 3.30GBX 3.11
-5.76%
GBX 3.30GBX 2.921.29 million shs£12.33 million
06/04/2026GBX 3.10GBX 3.30
+6.45%
GBX 3.30GBX 2.701.63 million shs£13.08 million
06/03/2026GBX 2.95GBX 3.10
+5.08%
GBX 3.20GBX 2.70379,483 shs£12.29 million
06/02/2026GBX 2.86GBX 2.95
+3.15%
GBX 3.20GBX 2.9596,451 shs£11.69 million
06/01/2026GBX 2.88GBX 2.86
-0.52%
GBX 3.20GBX 2.70301,073 shs£11.34 million
05/29/2026GBX 2.86GBX 2.88
+0.52%
GBX 3.20GBX 2.70403,880 shs£11.40 million
05/28/2026GBX 2.87GBX 2.86
-0.28%
GBX 3.10GBX 2.8620,992 shs£11.34 million
05/27/2026GBX 2.85GBX 2.87
+0.63%
GBX 3.10GBX 2.70591,018 shs£11.37 million
05/26/2026GBX 3.05GBX 2.85
-6.56%
GBX 3.10GBX 2.70540,646 shs£11.30 million
05/25/2026GBX 3.05GBX 3.05GBX 3.09GBX 2.7098,793 shs£12.09 million
05/22/2026GBX 2.80GBX 3.05
+8.93%
GBX 3.09GBX 2.7098,793 shs£12.32 million
05/21/2026GBX 3GBX 2.80
-6.67%
GBX 3GBX 2.721.46 million shs£11.10 million
05/20/2026GBX 2.93GBX 3
+2.28%
GBX 3.30GBX 2.701.57 million shs£11.89 million
05/19/2026GBX 3.08GBX 2.93
-4.62%
GBX 3.30GBX 2.931.82 million shs£13.17 million
05/18/2026GBX 3.63GBX 3.08
-15.29%
GBX 3.70GBX 3.081.42 million shs£12.19 million
05/15/2026GBX 3.34GBX 3.63
+8.68%
GBX 3.63GBX 31.75 million shs£14.39 million
05/14/2026GBX 3.44GBX 3.34
-2.91%
GBX 3.50GBX 33.53 million shs£13.24 million
05/13/2026GBX 3.50GBX 3.44
-1.71%
GBX 3.90GBX 3.303.76 million shs£14.47 million
05/12/2026GBX 3.30GBX 3.50
+6.06%
GBX 3.76GBX 3.392.69 million shs£13.87 million
05/11/2026GBX 3.02GBX 3.30
+9.27%
GBX 3.57GBX 34.08 million shs£13.08 million
05/08/2026GBX 2.80GBX 3.02
+7.86%
GBX 3.20GBX 2.933.79 million shs£11.97 million
05/07/2026GBX 2.52GBX 2.80
+11.11%
GBX 3.20GBX 2.556.85 million shs£11.10 million
05/06/2026GBX 2.50GBX 2.52
+0.80%
GBX 2.66GBX 2.111.95 million shs£9.99 million
05/05/2026N/AGBX 2.50GBX 2.80GBX 2.50249,267 shs£9.91 million

This page (LON:CIZ) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners